SCHEMBL7456183

SCHEMBL7456183

CCOC(=O)CN(CCCC(C)=O)C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA14 Q9ULX7 1/20 0.40
HDAC6 Q9UBN7 2/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
GAA P10253 2/20 0.34
CYP1A2 P05177 2/20 0.34
ALOX5 P09917 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
MGAM O43451 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5786967 0.91 CA12 (0.37) CA14HDAC6HDAC1HDAC2CA12
SCHEMBL7106444 0.90 CA14 (0.42) CA14HDAC6HDAC1HDAC2GAA
SCHEMBL2217787 0.87 CA14 (0.43) CA14HDAC6HDAC1HDAC2CA12
SCHEMBL15312506 0.86 SMN1; SMN2 (0.38) CA14HDAC6HDAC1HDAC2CA12
SCHEMBL11928368 0.85 CA14 (0.40) CA14HDAC6HDAC1HDAC2CA12
SCHEMBL23765759 0.84 CA12 (0.39) CA14HDAC6HDAC1HDAC2CA12
SCHEMBL29285429 0.84 CA14 (0.47) CA14HDAC6HDAC1HDAC2GAA
SCHEMBL18758783 0.84 CA12 (0.43) CA14HDAC6HDAC1HDAC2CA12
SCHEMBL20379769 0.84 CA14 (0.38) CA14HDAC6HDAC1HDAC2CA12
SCHEMBL1280292 0.83 SSTR4 (0.40) CA14HDAC6HDAC1HDAC2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040111-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-10-04 EP disclosed
WO-1999031099-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1999-06-24 WO disclosed